PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Follitropin delta
Presentation Product Chemical substance Chapter Items dispensed
Follitropin delta 12micrograms/0.36ml inj cartridges
0605010AFAAAAAA
Follitropin delta Follitropin delta Endocrine System No data available
Follitropin delta 12micrograms/0.36ml inj pf dispos dev
0605010AFAAADAD
Follitropin delta Follitropin delta Endocrine System No data available
Follitropin delta 36micrograms/1.08ml inj cartridges
0605010AFAAABAB
Follitropin delta Follitropin delta Endocrine System No data available
Follitropin delta 36micrograms/1.08ml inj pf dispos dev
0605010AFAAAFAF
Follitropin delta Follitropin delta Endocrine System No data available
Follitropin delta 72micrograms/2.16ml inj cartridges
0605010AFAAACAC
Follitropin delta Follitropin delta Endocrine System No data available
Follitropin delta 72micrograms/2.16ml inj pf dispos dev
0605010AFAAAEAE
Follitropin delta Follitropin delta Endocrine System No data available
Rekovelle 12micrograms/0.36ml inj cartridges
0605010AFBBAAAA
Rekovelle Follitropin delta Endocrine System No data available
Rekovelle 12micrograms/0.36ml inj pre-filled pens
0605010AFBBADAD
Rekovelle Follitropin delta Endocrine System No data available
Rekovelle 36micrograms/1.08ml inj cartridges
0605010AFBBABAB
Rekovelle Follitropin delta Endocrine System No data available
Rekovelle 36micrograms/1.08ml inj pre-filled pens
0605010AFBBAFAF
Rekovelle Follitropin delta Endocrine System No data available
Rekovelle 72micrograms/2.16ml inj cartridges
0605010AFBBACAC
Rekovelle Follitropin delta Endocrine System No data available
Rekovelle 72micrograms/2.16ml inj pre-filled pens
0605010AFBBAEAE
Rekovelle Follitropin delta Endocrine System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.